Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Wilcox

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The American Journal of Nursing|September 1, 1981
Benign breast disordersP M Wilcox
Lippincott'S Primary Care Practice|June 30, 1998
Breast cancer and gene testing: risk, rationale, and responsibilities of primary care providersP M Wilcox-Honnold
Hospital Practice (Office Ed.)|September 30, 1987
Benign breast disorders: a symptomatic approachD S Ettinger, P M Wilcox
Primary Care|December 1, 1977
Benign breast disease. Diagnosis and treatmentP M Wilcox, D S Ettinger
Current Opinion in Oncology|December 1, 1990
High-risk groups and preventive measures in breast cancerP M Wilcox, M E Stefanek
Preventive Medicine|July 1, 1995
Predictors of and satisfaction with bilateral prophylactic mastectomyM E Stefanek, K J Helzlsouer, P M Wilcox, et al.
Cancer Treatment Reports|August 1, 1982
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinomaP M Wilcox, J H Fetting, K M Nettesheim, et al.
Nature Genetics|December 1, 1995
Informed consent and BRCA1 testingG Geller, B A Bernhardt, K Helzlsouer, et al.
Medical and Pediatric Oncology|January 1, 1979
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breastW P Vaughan, P M Wilcox, P O Alderson, et al.
Cancer Practice|May 1, 1996
Options for breast cancer treatmentL J Hilderly, P M Wilcox, R E Pollock, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The American Journal of Nursing|September 1, 1981
Benign breast disordersP M Wilcox
Lippincott'S Primary Care Practice|June 30, 1998
Breast cancer and gene testing: risk, rationale, and responsibilities of primary care providersP M Wilcox-Honnold
Hospital Practice (Office Ed.)|September 30, 1987
Benign breast disorders: a symptomatic approachD S Ettinger, P M Wilcox
Primary Care|December 1, 1977
Benign breast disease. Diagnosis and treatmentP M Wilcox, D S Ettinger
Current Opinion in Oncology|December 1, 1990
High-risk groups and preventive measures in breast cancerP M Wilcox, M E Stefanek
Preventive Medicine|July 1, 1995
Predictors of and satisfaction with bilateral prophylactic mastectomyM E Stefanek, K J Helzlsouer, P M Wilcox, et al.
Cancer Treatment Reports|August 1, 1982
Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinomaP M Wilcox, J H Fetting, K M Nettesheim, et al.
Nature Genetics|December 1, 1995
Informed consent and BRCA1 testingG Geller, B A Bernhardt, K Helzlsouer, et al.
Medical and Pediatric Oncology|January 1, 1979
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breastW P Vaughan, P M Wilcox, P O Alderson, et al.
Cancer Practice|May 1, 1996
Options for breast cancer treatmentL J Hilderly, P M Wilcox, R E Pollock, et al.
Pageof 2